BioAtla is a protein therapeutic company that uses discovery and evolution to develop safer and more potent drugs for the treatment of cancer. The culmination of our discovery and evolution expertise and more than 150 issued patents and patent applications is our Conditionally Active Biologics (CAB) platform, whereby monoclonal antibodies or other biologics can be engineered for selective conditional activation, for example preferential binding under the unique conditions of the tumor microenvironment. This improvement in tumor selectivity helps address the issue of on-target toxicity and improve therapeutic index. BioAtla is applying these technologies in our own pipeline and in partnerships to ultimately deliver better immunotherapies for cancer.
Company Details
- Employees
- 56
- Founded
- -
- Address
- 11085 Torreyana Rd, San Diego,california 92121,united States
- Phone
- 1(858) 558-0708
- in****@****tla.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bioatla.com
- Keywords
- antibody evolution and engineering, protein evolution and engineering, development of novel cancer immunotherapies, conditionally active biologics.
- HQ
- San Diego, California
Bioatla, Inc. Questions
Bioatla, Inc.'s helpline number is 1(858) 558-0708
Bioatla, Inc.'s website is bioatla.com
Bioatla, Inc.'s LinkedIn profile is https://www.linkedin.com/company/bioatla
Bioatla, Inc. has
56 employees.
View email and phone details for 56
employees at Bioatla, Inc..
Bioatla, Inc.'s industry is
Biotechnology Research
Bioatla, Inc.'s top competitors are
Pyxis Oncology,
Carisma Therapeutics,
Lifemine Therapeutics,
Vaxart, Inc.,
Nkarta, Inc.,
Lyndra Therapeutics,
Sutro Biopharma, Inc.,
College Pulse,
Context Therapeutics,
Inspirna, Inc..
Bioatla, Inc.'s support email address is info@bioatla.com
Bioatla, Inc.'s categories are Biotechnology Research
Bioatla, Inc.'s founding year is 2007
